AzTrials
AzTrials

Acute Respiratory Distress SyndromePROLOADNCT05898269

Fluid Responsiveness Prediction During Prone Position

A study testing Trendelenburg maneuver, End-expiratory occlusion test (EE OCC) and End-expiratory and end-inspiratory occlusion test (EI OCC) in people with Acute Respiratory Distress Syndrome, run by Hospices Civils de Lyon at 4 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Predicting fluid responsiveness is primordial when caring for patients with circulatory shock as it allows correction of preload-dependent low cardiac output states, while preserving patients of the deleterious effects of excessive fluid resuscitation. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acute Respiratory Distress Syndrome
What is being tested?
Trendelenburg maneuver, End-expiratory occlusion test (EE OCC) and End-expiratory and end-inspiratory occlusion test (EI OCC)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
96 participants
Where
4 sitesFrance
Study dates
6 Oct 2023to Oct 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adult patient (including patient under protective measures/wardship)
  • with ARDS as defined by the Berlin criteria
  • in the prone position as per international guidelines
  • with a calibrated continuous cardiac output monitoring device
  • with a clinical indication for a fluid bolus as prescribed by the clinician in charge, and fulfilling at least 2 clinical criteria: mottles, tachycardia, hypotension, drop in cardiac output, oliguria, high arterial lactate concentration, or any other detailed criterion
  • with no respiratory efforts

Who cannot join

  • acute cor pulmonale
  • patient treated with veno-venous extra-corporeal membrane oxygenation
  • hemorrhagic shock
  • Child-Pugh C cirrhosis
  • death expected to occur in less than 24h
  • decision to withhold or suspend active treatments
Show all 15Show fewer
  • intracranial hypertension
  • lower limb amputation
  • obstruction of the inferior vena cava
  • acute abdominal syndrome
  • absence of consent to participate
  • pregnancy
  • patient previously enrolled in the same study
  • lack of affiliation to a social security regimen, as per French legislation
  • patient deprived of its liberty

Trial locations and contacts

4 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Mathieu Jozwiak, Dr contact

4 92 03 55 10 ext. +33

France4 sites, 4 recruiting
  • CHU Gabriel Montpied

    Clermont-Ferrand, 63000

    Claire Dupuis, Dr, 4 73 75 49 82 ext. +33, cdupuis1@chu-clermontferrand.fr

    Not yet recruiting
  • Hôpital de la Croix Rousse, Hospices Civils de Lyon

    Lyon, 69004

    Laurent BITKER, Dr, 4 26 10 94 93 ext. +33, laurent.bitker@chu-lyon.fr

    Recruiting
  • CHU de Nice - l'Archet 1

    Nice, 06200

    Mathieu Jozwiak, Dr, 4 92 03 55 10 ext. +33, jozwiak.m@chu-nice.fr

    Not yet recruiting
  • CHU Nice - Pasteur 2

    Nice, 06200

    Denis DOYEN, Dr, 04 92 03 55 10 ext. +33, doyen.d@chu-nice.fr

    Not yet recruiting

Other trials in France

About this study

Official title: Evaluation of the Diagnostic Performance of 4 Dynamic Tests Evaluating Preload Dependence in Patients With Acute Respiratory Distress Syndrome in the Prone Position

Predicting fluid responsiveness is primordial when caring for patients with circulatory shock as it allows correction of preload-dependent low cardiac output states, while preserving patients of the deleterious effects of excessive fluid resuscitation.

Patients with severe acute respiratory distress syndrome (ARDS) treated with prone positioning (PP) are a specific subset of patients, as 1) they frequently present with shock; 2) excessive fluid administration may lead to respiratory worsening due to increased hydrostatic oedema with potential subsequent worse clinical outcome; and 3) all available dynamic tests evaluating fluid responsiveness can only be performed in patients in the supine condition (which in the case of severe ARDS patients in PP occurs only for 8h over 24h). These elements warrant the development of specific tests allowing the clinician to predict fluid responsiveness with enough exactitude when caring for these patients.

Read more

We hypothesize that there exists diagnostic heterogeneity in the predictive performance of 4 clinical tests to identify fluid responsiveness in ARDS patients in PP. For the matter of this study, these 4 tests are the Trendelenburg maneuver, the end-expiratory occlusion test, the end-expiratory occlusion test associated with the end-inspiratory occlusion test, and the tidal volume challenge. The diagnostic reference of the study will be the relative change in cardiac index measured by transpulmonary thermodilution before and after a 500 ml fluid bolus, and will allow the adjudication of patients as being fluid responsive or not.

The primary objective of the study is to determine the area under the ROC curve of each of the 4 tests, with their respective 95% confidence interval.

All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. Patients will only participate once. The expected duration of study participation is 30 minutes maximum.

Being tested
Trendelenburg maneuver, End-expiratory occlusion test (EE OCC), End-expiratory and end-inspiratory occlusion test (EI OCC), Tidal volume challenge, Fluid bolus (reference diagnostic method)
Keywords
Acute respiratory distress syndrome, Fluid responsiveness, Fluid resuscitation, Cardiac output, Cardiac preload, Prone position, Continuous cardiac output monitoring
Medical subject headings
Respiratory Distress Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Trendelenburg maneuverDiagnostic test

    Bed tilting from the +13° position to the -13° position for 60 seconds. Evaluator: relative change in continuous cardiac index between baseline, and the highest value observed during the maneuver

  • End-expiratory occlusion test (EE OCC)Diagnostic test

    End-expiratory pause performed on the ventilator, and maintained for 15 seconds.

    Evaluator: relative change in continuous cardiac index between baseline, and the value observed in the last 5 seconds of the respiratory pause

  • End-expiratory and end-inspiratory occlusion test (EI OCC)Diagnostic test

    End-inspiratory pause performed on the ventilator, and maintained for 15 seconds.

    Evaluator: relative change in continuous cardiac index between baseline, and the value observed in the last 5 seconds of the respiratory pause. The evaluator is calculated as the sum of the relative change in cardiac index observed during the end-expiratory pause and that of the end-inspiratory pause. Hence, for this test, the evaluator will be coupled with that of intervention 2 (end-expiratory occlusion test).

  • Tidal volume challengeDiagnostic test

    Increase in tidal volume set on the ventilator from 6 ml.kg-1 of predicted body weight, to 8 ml.kg-1 for 60 seconds.

    Evaluator: difference in the pulse pressure variation measured at 6 ml.kg-1 and at 8 ml.kg-1.

  • Fluid bolus (reference diagnostic method)Diagnostic test

    After the 4 tests, the patient will receive a 500-ml fluid bolus of crystalloids in less than 15 minutes.

    Evaluator (reference method): cardiac index measured by transpulmonary thermodilution before and immediately after the fluid bolus. Patients with a relative change in cardiac index > 15% will be identified as being fluid responders, and the others as non-responders.

Study groups in NCT05898269
Study groupRoleWhat they receive
Trendelenburg maneuver-EE OCC-EI OCC-Tidal volume challengeExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
Trendelenburg maneuver-EE OCC-Tidal volume challenge-EI OCCExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
Trendelenburg maneuver-Tidal volume challenge-EI OCC-EE OCCExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
Trendelenburg maneuver-Tidal volume challenge-EE OCC-EI OCCExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
Trendelenburg maneuver-EI OCC-Tidal volume challenge-EE OCCExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
Trendelenburg maneuver-EI OCC-EE OCC-Tidal volume challengeExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
EE OCC-EI OCC-Tidal volume challenge-Trendelenburg maneuverExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
EE OCC-EI OCC-Trendelenburg maneuver-Tidal volume challengeExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
EE OCC-Tidal volume challenge-Trendelenburg maneuver-EI OCCExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
EE OCC-Tidal volume challenge-EI OCC-Trendelenburg maneuverExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
EE OCC-Trendelenburg maneuver-Tidal volume challenge-EI OCCExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
EE OCC-Trendelenburg maneuver-EI OCC-Tidal volume challengeExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
EI OCC-Tidal volume challenge-EE OCC-Trendelenburg maneuverExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
EI OCC-Tidal volume challenge-Trendelenburg maneuver-EE OCCExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
EI OCC-Trendelenburg maneuver-EE OCC-Tidal volume challengeExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
EI OCC-Trendelenburg maneuver-Tidal volume challenge-EE OCCExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
EI OCC-EE OCC-Trendelenburg maneuver-Tidal volume challengeExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
EI OCC-EE OCC-Tidal volume challenge-Trendelenburg maneuverExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
Tidal volume challenge-EI OCC-EE OCC-Trendelenburg maneuverExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
Tidal volume challenge-EI OCC-Trendelenburg maneuver-EE OCCExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
Tidal volume challenge-Trendelenburg maneuver-EE OCC- EI OCCExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
Tidal volume challenge-Trendelenburg maneuver- EI OCC-EE OCCExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
Tidal volume challenge-EE OCC-Trendelenburg maneuver- EI OCCExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)
Tidal volume challenge-EE OCC- EI OCC-Trendelenburg maneuverExperimentalAll enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Receives: Diagnostic Test: Trendelenburg maneuver; Diagnostic Test: End-expiratory occlusion test (EE OCC); Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC); Diagnostic Test: Tidal volume challenge; Diagnostic Test: Fluid bolus (reference diagnostic method)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Area under the ROC curve (AUROC) of the evaluated tests.

    The AUROC will be determined for each of the 4 clinical tests evaluated in this study. The reference method to define the AUROC to design the curve will be the fluid responsive status (responder vs. non-responder) as determined by the fluid bolus. For each test, the AUROC will be accompanied with its 95% confidence interval.

    Measured: 30 minutes

Secondary outcomes (4)
  1. Comparison of diagnostic performance of the evaluated tests.

    For this outcome measure, the AUROCs will be determined as for the primary outcome measure. The AUROCs will be compared using the Delong's method, with adjustments for the repetition of measurements in a single patient.

    Measured: 30 minutes

  2. Diagnostic performance metrics of each test

    Sensitivity, specificity, positive predictive value, negative predictive value and likelihood ratios of the evaluated tests, computed for the optimal diagnostic threshold determined using the Youden J index of the ROC curve. The optimal threshold will only be computed for AUROCs significantly different from 0.5.

    Measured: 30 minutes

  3. Weighted diagnostic performance of each test

    Sensitivity, specificity, positive predictive value, negative predictive value and likelihood ratios of the evaluated tests, computed for the optimal diagnostic threshold determined using the Youden J index of the ROC curve, and adjusted using weighting based on the clinical tradeoff of the subsequent fluid bolus on hemodynamic benefit vs. the respiratory risk. The optimal threshold will only be computed for AUROCs significantly different from 0.5.

    Measured: 30 minutes

  4. Grey zone area of the optimal diagnostic threshold of each test

    Determination of the boundaries of a grey zone around the value of the optimal threshold of each test, in which the diagnostic performance is deemed clinically insufficient (excessive misclassification risk due to lack of discrimination). The grey zone around the optimal threshold will only be computed for AUROCs significantly different from 0.5.

    Measured: 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2023
  2. Study start6 Oct 2023
  3. Primary completionOct 2026 (estimated)
  4. Study completionOct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
96 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05898269
Sponsor's protocol ID
69HCL23_0315
Other IDs
2023-A00920-45
Acronym
PROLOAD
Status last verified
Jan 2024
First submitted
1 Jun 2023
Last updated
18 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Trendelenburg maneuver, End-expiratory occlusion test (EE OCC) and End-expiratory and end-inspiratory occlusion test (EI OCC) in people with Acute Respiratory Distress Syndrome, run by Hospices Civils de Lyon at 4 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Laurent BITKER, Dr (4 26 10 94 93 ext. +33, laurent.bitker@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Area under the ROC curve (AUROC) of the evaluated tests. (time frame: 30 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in